We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
MP Materials
MP
$7.41B
| $1.91M | ﹤0.01% |
57,549
-28,618
| -33% | -$730K |
2021 Q4
14 quarters
|
|
952
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$6.76B
| – | – |
0
| – | – |
2024 Q4
2 quarters
|
|
953
Patria Investments
PAX
$1.94B
| $1.9M | ﹤0.01% |
135,000
| – | – |
2021 Q1
17 quarters
|
|
954
Bunge Global
BG
$20.6B
| $1.9M | ﹤0.01% |
23,620
-14,178
| -38% | -$1.12M |
2018 Q2
28 quarters
|
|
955
Steven Madden
SHOO
$3.38B
| $1.89M | ﹤0.01% |
78,802
-454,312
| -85% | -$10.7M |
2024 Q4
2 quarters
|
|
956
Compass Diversified
CODI
$799M
| $1.88M | ﹤0.01% |
+299,774
| New | +$3.34M |
2025 Q2
0 quarters
|
|
957
Zegna
ZGN
$3.59B
| $1.88M | ﹤0.01% |
220,000
+80,000
| +57% | +$645K |
2025 Q1
1 quarter
|
|
958
Oil States International
OIS
$479M
| $1.86M | ﹤0.01% |
346,435
+7,690
| +2% | +$34K |
2024 Q1
5 quarters
|
|
959
Keysight
KEYS
$58.2B
| $1.85M | ﹤0.01% |
11,307
+890
| +9% | +$136K |
2014 Q4
42 quarters
|
|
960
COPT Defense Properties
CDP
$3.77B
| $1.85M | ﹤0.01% |
66,936
+49,704
| +288% | +$1.35M |
2013 Q2
48 quarters
|
|
961
LifeMD
LFMD
$119M
| $1.84M | ﹤0.01% |
+135,198
| New | +$1.28M |
2025 Q2
0 quarters
|
|
962
Infosys
INFY
$49.1B
| $1.83M | ﹤0.01% |
98,902
+2,370
| +2% | +$42.3K |
2023 Q1
9 quarters
|
|
963
Magnolia Oil & Gas
MGY
$6.6B
| $1.83M | ﹤0.01% |
81,508
-38,726
| -32% | -$858K |
2024 Q2
4 quarters
|
|
964
Ashland
ASH
$3.28B
| $1.83M | ﹤0.01% |
36,438
+17,870
| +96% | +$909K |
2013 Q2
48 quarters
|
|
965
Graco
GGG
$13.2B
| $1.83M | ﹤0.01% |
21,289
+852
| +4% | +$70.6K |
2013 Q2
48 quarters
|
|
|
966
Bristol-Myers Squibb
BMY
$124B
| $1.83M | ﹤0.01% |
39,478
-7,793,300
| -99% | -$383M |
2013 Q2
48 quarters
|
|
967
DELISTED
Webster Financial
WBS
| $1.82M | ﹤0.01% |
33,360
+14,226
| +74% | +$709K |
2013 Q2
48 quarters
|
|
968
Principal Financial Group
PFG
$23.3B
| $1.81M | ﹤0.01% |
22,767
-1,139
| -5% | -$87.4K |
2013 Q2
48 quarters
|
|
969
Emergent Biosolutions
EBS
$368M
| $1.78M | ﹤0.01% |
279,469
+328
| +0.1% | +$1.88K |
2015 Q3
39 quarters
|
|
970
Hanover Insurance
THG
$7.95B
| $1.78M | ﹤0.01% |
10,481
-2,761
| -21% | -$461K |
2013 Q2
48 quarters
|
|
971
Financial Institutions
FISI
$774M
| $1.78M | ﹤0.01% |
69,125
-149
| -0.2% | -$3.72K |
2013 Q2
48 quarters
|
|
972
DELISTED
Arcellx
ACLX
| $1.77M | ﹤0.01% |
26,935
-19,289
| -42% | -$1.2M |
2022 Q4
10 quarters
|
|
973
Casey's General Stores
CASY
$24.9B
| $1.77M | ﹤0.01% |
3,465
-50
| -1% | -$23K |
2013 Q2
48 quarters
|
|
974
Bread Financial
BFH
$3.89B
| $1.76M | ﹤0.01% |
30,818
-264
| -0.8% | -$13.3K |
2013 Q2
48 quarters
|
|
975
Southwest Gas
SWX
$6.24B
| $1.76M | ﹤0.01% |
23,656
-6,509
| -22% | -$469K |
2015 Q4
38 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.